Analysts Set Teleflex Incorporated (NYSE:TFX) Price Target at $252.50

Teleflex Incorporated (NYSE:TFX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the seven analysts that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $252.50.

Several equities research analysts have recently issued reports on TFX shares. Royal Bank of Canada lowered their price objective on Teleflex from $275.00 to $245.00 and set an "outperform" rating for the company in a research note on Friday, November 1st. StockNews.com raised shares of Teleflex from a "hold" rating to a "buy" rating in a research report on Thursday, November 28th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a research note on Monday, December 16th. Mizuho decreased their price target on Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a research note on Friday, November 1st. Finally, Truist Financial cut their price objective on Teleflex from $227.00 to $200.00 and set a "hold" rating on the stock in a research report on Wednesday, December 18th.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the company. Oregon Public Employees Retirement Fund grew its holdings in Teleflex by 1.2% in the second quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company's stock worth $846,000 after purchasing an additional 46 shares during the last quarter. Cromwell Holdings LLC increased its position in Teleflex by 59.0% during the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company's stock valued at $33,000 after buying an additional 49 shares in the last quarter. Crossmark Global Holdings Inc. raised its stake in Teleflex by 1.9% in the second quarter. Crossmark Global Holdings Inc. now owns 2,779 shares of the medical technology company's stock valued at $584,000 after buying an additional 53 shares during the last quarter. Apollon Wealth Management LLC boosted its holdings in Teleflex by 3.7% in the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company's stock worth $377,000 after acquiring an additional 55 shares in the last quarter. Finally, SRS Capital Advisors Inc. grew its stake in shares of Teleflex by 0.3% during the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company's stock worth $4,844,000 after acquiring an additional 60 shares during the last quarter. Institutional investors own 95.62% of the company's stock.

Teleflex Price Performance

Shares of NYSE:TFX traded down $0.99 during mid-day trading on Wednesday, reaching $177.26. The stock had a trading volume of 114,964 shares, compared to its average volume of 388,592. The company has a market cap of $8.23 billion, a P/E ratio of 35.24, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. The business's 50 day moving average price is $200.10 and its 200 day moving average price is $218.94. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex has a 1 year low of $171.69 and a 1 year high of $256.85.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, beating the consensus estimate of $3.38 by $0.11. The business had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Teleflex's quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter last year, the business earned $3.64 earnings per share. Research analysts expect that Teleflex will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Friday, November 15th were given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.77%. The ex-dividend date was Friday, November 15th. Teleflex's payout ratio is 27.04%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.